Latest Health stories from Life.
While there is a sense of optimism regarding Trump's choice for the CDC, employees express a cautious outlook, especially concerning RFK Jr.'s involvement.
This overview discusses the Kemp-Kasten amendment, which restricts U.S. funding to organizations like UNFPA based on their involvement with coercive abortion or involuntary sterilization.
Paul Oberstein from NYU Langone's Perlmutter Cancer Center suggests that recent developments in pancreatic cancer treatment could signify a major shift in medical approaches.
A recent analysis reveals trends in employer-based health insurance, affecting 165.6 million individuals under 65 years old as of March 2025.
The FDA is reportedly considering a broader application of testosterone therapy aimed at enhancing libido, amidst ongoing discussions in the biotech sector.
Recent research sheds light on the potential risks associated with ICE detention, alongside discussions on GLP-1s and vaccine skepticism.
The pharmaceutical industry is experiencing a wave of personnel changes, including new hires, promotions, and departures. Here’s a summary of the latest developments.
A recent small study suggests that pre-transplant cell therapy may enable some liver transplant patients to discontinue the use of immunosuppressive drugs, indicating a potential shift in treatment approaches.
Recent headlines may suggest a growing skepticism towards vaccines among Americans, but a new poll indicates that this perception may not reflect reality.
As cyberattacks on health care systems escalate, the potential for patient harm grows. Andrea Downing highlights the urgent need for improved defenses against these threats.
A recent ruling provides important insights into navigating issues related to the No Surprises Act, particularly regarding arbitration decisions.
Recent updates on MAHA highlight a significant breakthrough in Duchenne muscular dystrophy, alongside ongoing challenges in cancer treatment and other health developments.
A mother's determination has reignited interest in a neglected class of drugs, potentially benefiting her son and many others with neuromuscular disorders.
A federal judge Tuesday refused to block filling prescriptions for the abortion pill mifepristone by mail across the U.S. — at least for now.
Strategic angle: This tracker provides up-to-date information on countries with signed bilateral MOU global health agreements with the U.S.
Strategic angle: Insurers score Medicare Advantage wins, the obesity drug race continues, and other biotech news from The Readout.
Strategic angle: This policy watch examines the United States’ measles elimination status and the potential threats to it.
Strategic angle: In this edition of STAT Health Tech: UnitedHealth Group's big bet on AI to transform its operations, venture funding trends, and more.
Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal.
Strategic angle: Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.